Results for category "Cancer therapies"

How Oncotarget Has Helped Cancer Doctors

Oncologists are able to have a peer review publication they can rely on for the first time in a long time. Because Mikhail Blagosklonny worked hard to make things better for cancer doctors around the world, he knew he would be able to actually help more people than just those who were working as oncologists. He also knew things would continue to get better as long as he was showing all the people the right thing to do while they were using the publication. Because Mikhail Blagosklonny has grown Oncotarget to the point where it is today, he feels confident he can continue to help people.When Oncotarget was first published, Mikhail Blagosklonny made sure it was something people would be able to use as long as they were working as oncologists. They had learned a lot from the publication and could come up with new ideas based on the publication while they were understanding it. No matter what Mikhail Blagosklonny did with it, people were benefitting from it and learning more about cancer treatment options they could use for their own patients no matter what type of cancer they were suffering from or what stage they were in after being diagnosed.

After Mikhail Blagosklonny realized other providers could bring value to the publication, he made the choice to include them in it. He wanted to show people they could actually receive the best help possible if they were taking advice from other specialists. The only requirement of Mikhail Blagosklonny had when it came to getting this advice from people was that they make sure they were actually doing everything they could to help cancer patients instead of just focusing on helping people to satisfy their own needs in different areas of the types of treatment they were studying.For years, Mikhail Blagosklonny made the choices that came along with running Oncotarget. He still continues to help providers have a clear idea of what they can use the publication for, but he knows it will be something he can continue for years to come.

When other specialists are able to help those who are working on treating cancer, the cancer doctors are able to learn as much as possible. In turn, they are able to save people more than they would have without the special techniques provided by other doctors that they have found listed in the peer review publications.Even those who are studying to become oncologists can benefit from Oncotarget. Mikhail Blagosklonny wanted students to have access to the publication so they could use it in their studies. He chose to make things easy for these students in every way possible. He believed students were the future of the cancer treatment opportunities so he pushed forward to make things better for all the people who were in those situations. He wanted them to have the best opportunities possible no matter what they were doing on their own or in other situations with the people who they continued to work with.